期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 24, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/ijms24108859
关键词
JAK/STAT3 signaling pathway; STAT3 inhibitors; ageladine A derivatives; dibromo pyrrole-imidazole; antitumor mechanisms; antitumor activities
In this study, several ageladine A derivative compounds were synthesized and compound 25 was found to be the most effective. Compound 25 showed inhibitory effects on STAT3 activation, reducing the expression of downstream genes and suppressing tumor cell proliferation and migration. In vivo experiments demonstrated that compound 25 effectively inhibited the growth of A549 tumors without significant weight loss.
The Janus kinase/signal transducer and activator of the transcription 3 (JAK/STAT3) signaling pathway controls multiple biological processes, including cell survival, proliferation, and differentiation. Abnormally activated STAT3 signaling promotes tumor cell growth, proliferation, and survival, as well as tumor invasion, angiogenesis, and immunosuppression. Hence, JAK/STAT3 signaling has been considered a promising target for antitumor therapy. In this study, a number of ageladine A derivative compounds were synthesized. The most effective of these was found to be compound 25. Our results indicated that compound 25 had the greatest inhibitory effect on the STAT3 luciferase gene reporter. Molecular docking results showed that compound 25 could dock into the STAT3 SH2 structural domain. Western blot assays demonstrated that compound 25 selectively inhibited the phosphorylation of STAT3 on the Tyr705 residue, thereby reducing STAT3 downstream gene expression without affecting the expression of the upstream proteins, p-STAT1 and p-STAT5. Compound 25 also suppressed the proliferation and migration of A549 and DU145 cells. Finally, in vivo research revealed that 10 mg/kg of compound 25 effectively inhibited the growth of A549 xenograft tumors with persistent STAT3 activation without causing significant weight loss. These results clearly indicate that compound 25 could be a potential antitumor agent by inhibiting STAT3 activation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据